Explore recent US developments on federal drug price negotiation expansion to commercial plans, DEA telehealth prescribing extensions, the 340B rebate pilot launch, and ACA subsidy debates in the Senate impacting insurance and healthcare markets.
Explore the latest U.S. market insights on exoskeleton and wearable robotics technology, including Medicare Advantage reimbursement expansions, regulatory certifications, and industrial applications enhancing worker safety and rehabilitation.
Galen Centre recommends mandatory health screenings for Malaysian medical insurance buyers to address high NCD prevalence and improve underwriting and claims fairness.
Eli Lilly's Mounjaro joins China's national health insurance list for type 2 diabetes, enhancing accessibility amid pricing adjustments. Related diabetes therapies and market impacts examined.
Massachusetts Health Connector opens 2025 enrollment with in-person Navigator support, highlighting subsidy availability and upcoming changes in federal tax credits affecting premiums.
ACA marketplace premiums in Nebraska are expected to rise sharply in 2026 due to expiring tax credits. Many consumers face significant coverage affordability challenges as federal subsidies end.
Gold prices edged higher due to a softer U.S. dollar amid expectations of an upcoming Federal Reserve interest rate reduction. This shift highlights the impact of monetary policy on financial and commodity markets.
Brocker, Karns and Karns provides independent insurance coverage options across Iowa, partnering with Auto-Owners Insurance for competitive rates on home, auto, life, and business policies.
Despite a citywide decline in car break-ins, Atlanta neighborhoods near Grant Park experienced over 100 vehicle break-ins in a single night, highlighting localized security challenges and insurance implications.
China launches its first Commercial Health Insurance Innovative Drug List with CAR-T therapies, advancing access to innovative cancer and rare disease treatments under commercial insurance.
